Skip to main content
CRS 2024 Annual Meeting and Exposition Main banner
Final Program


CRS Abstract Guide
Back

Xiaoling Li, PhD (he/him/his)

Professor
University of the Pacific
Stockton, California, United States

Xiaoling Li, Ph.D. is a Professor of Pharmaceutics in Thomas J. Long School of Pharmacy at the University of the Pacific. Dr. Li is a Fellow of American Association of Pharmaceutical Scientists and a Fellow of American Institute for Medical and Biological Engineering. He received BS in Pharmacy and MS in Nuclear Pharmacy from Shanghai Medical University in 1982 and 1985, respectively, and PhD in Pharmceutics from Univeristy of Utah. Prior to his academic career, he was a postdoctoral research fellow at Ciba-Geigy Corp (now Novartis). He served as department chair, graduate program director and Associate Dean of Graduate Education and Research during his tenure at University of the Pacific. He holds 25 patents with 45 patent applications pending and has published 110 papers/book chapters, over 190 abstracts/presentations, and three books entitled “Design of Controlled Release Drug Delivery Systems”, “Oral Bioavailability”, and “Oral Bioavailability and Drug Deliver”. Dr. Li received CRS Outstanding Paper Award for the Journal of Controlled Release in 1992 and AAPS Outstanding Educator Award in 2015. He co-founded two companies, Formurex, Inc, a formulation development company in 2006 and Triastek, a 3D printing pharmaceutical company in 2015.

Disclosure information not submitted.

Presentation(s):